Candesant Biomedical

A clinical stage company driving research & development of a novel, investigational sweat control patch designed to offer underarm sweat relief with no downtime

[Practical Derm @Practical_Derm]

The U.S. FDA has cleared cleared Brella, the first 3-Minute SweatControl Patch to significantly reduce excessive underarm sweating in adults with primary axillary #hyperhidrosis. https://t.co/Q1NH7pFrv2

[Candesant Biomedical @CandesantBio]

If you haven’t already, check out the recent @Allure_magazine article highlighting the recent FDA Clearance of Brella™, the first and only 3-Minute SweatControl Patch™! #Brella #ExcessiveSweating #MyBrella #SweatControl

[Allure @Allure_magazine]

You wear one patch for three minutes on each underarm and this simple treatment could curb sweating for the next three to four months.

https://t.co/2Pf8CHaRLk

[Candesant Biomedical @CandesantBio]

Great news for the 80% of people with #ExcessiveSweating interested in a new technology to help control their sweat. The FDA granted a de novo request for Brella™, for the reduction of primary axillary (underarm) hyperhidrosis. Learn more: https://t.co/b5e4SQeqDF #MyBrella

[Candesant Biomedical @CandesantBio]

Read the recent @Medscape article featuring the FDA clearance of Brella™. #Brella provides a new in-office approach to sweat control that is fast, non-invasive, needle-free, aluminum-free, and affordable, with results lasting three to four months. #ExcessiveSweating #MyBrella

[Medscape @Medscape]

The FDA today cleared the first patch to reduce excessive underarm sweating for adults with primary axillary hyperhidrosis. https://t.co/TSKx4m4OBT

[Candesant Biomedical @CandesantBio]

Check out @Allure_magazine new article featuring Brella™, FDA-cleared for the reduction of excessive underarm sweating in adults with primary axillary hyperhidrosis. Read the article at https://t.co/rEEOUyFH5H. #Brella #ExcessiveSweating #MyBrella #SweatControlPatch

[Candesant Biomedical @CandesantBio]

Candesant Founder & CEO Niquette Hunt explains why the FDA clearance of #Brella is a game changer for adults with primary axillary hyperhidrosis (excessive underarm sweating). Learn more: https://t.co/7Uh8NTbiGr #ExcessiveSweating #MyBrella #SweatControlPatch

[Candesant Biomedical @CandesantBio]

The FDA granted a de novo request for #Brella, the first 3-Minute SweatControl Patch™, for the reduction of excessive underarm sweating in adults with primary axillary hyperhidrosis. Learn more: https://t.co/L8n525rfXI #ExcessiveSweating #MyBrella #SweatControl

[Candesant Biomedical @CandesantBio]

If you’re at #AAD2023, attend today's Late-Breaking Research Session at 10:10AM, where Dr. David Pariser will present data from the pivotal SAHARA trial which evaluated Candesant's investigational sweat control patch for primary axillary hyperhidrosis. #ExcessiveSweating

[Candesant Biomedical @CandesantBio]

At Candesant, the feedback from individuals and their doctors about current treatments for hyperhidrosis (#ExcessiveSweating) drives our commitment to developing a modern solution. Learn about our advances in #SweatTech: https://t.co/968wquZ9pU

[Candesant Biomedical @CandesantBio]

#SweatTalks. That's why 70% of those with #ExcessiveSweating have stated they alter their lifestyle to cope with it. Learn about new technology on the horizon that may change how excessive sweating is managed: https://t.co/968wquZ9pU #SweatTech

[Candesant Biomedical @CandesantBio]

Attending @OctaneOC Technology Forum this Thursday in Newport Beach CA? Don’t miss the “Business Development in Aesthetics” conversation as leaders including, our Founder & CEO, Niquette Hunt, discuss innovations and advancements in medical aesthetics. #SweatTech

[Candesant Biomedical @CandesantBio]

#ExcessiveSweating can cause #SweatStress which could be heightened when attending parties and celebrations with family and friends. Find out more about the impacts of excessive sweating: https://t.co/968wquZ9pU

[Candesant Biomedical @CandesantBio]

#SweatFact: the first antiperspirant that could be applied directly on the underarm with little irritation was developed in 1939. Learn how #SweatTech is continuing to lead to modern approaches for #ExcessiveSweating: https://t.co/968wquZ9pU

[Candesant Biomedical @CandesantBio]

The commitment to finding solutions for the millions of Americans with hyperhidrosis (#ExcessiveSweating) runs deep at Candesant. Check out how we are working to bring a modern, non-invasive option in #SweatTech: https://t.co/968wquYBAm

[Candesant Biomedical @CandesantBio]

Hear from three experts as they explain the impact of #ExcessiveSweating on those with it, and how #SweatTech technology could bring a modern solution: https://t.co/968wquZ9pU

[Candesant Biomedical @CandesantBio]

#DYK under the arms is the most common place people can experience hyperhidrosis (#ExcessiveSweating)? Learn about a modern treatment Candesant is developing, focused first on excessive underarm sweat: https://t.co/968wquYBAm #SweatFacts

[Candesant Biomedical @CandesantBio]

Don't sweat your New Year's resolution! Reduce your SweatStress by learning what's on the horizon in #SweatTech. Sign up today: https://t.co/968wquZ9pU #HappyNewYear #ExcessiveSweating

[Allure @Allure_magazine]

As I can attest, the condition can be debilitating.

https://t.co/YmDjNqs7NU

[Candesant Biomedical @CandesantBio]

Check out this article featuring our investigational “TAT” patch as a potential “revolutionary” treatment for #Hyperhidrosis and #ExcessiveSweating: https://t.co/clcxhbfiJg. We are excited for the future of #SweatTech and how our technology may contribute to #SweatControl.

[Candesant Biomedical @CandesantBio]

#ExcessiveSweating treatments have evolved as technology has advanced. Today, researchers are using #SweatTech to modernize solutions. Dr. Michael Kaminer explains what SweatTech means for future treatments. Find out more at https://t.co/968wquZ9pU